Alessandro Gasparini1, Marie Evans1, Josef Coresh2, Morgan E Grams2,3, Olof Norin4, Abdul R Qureshi1, Björn Runesson1, Peter Barany1, Johan Ärnlöv5,6, Tomas Jernberg7,8, Björn Wettermark9,10, Carl G Elinder1,9, Juan-Jesüs Carrero1,11. 1. Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden. 2. Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD, USA. 3. Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA. 4. Medical Management Center, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden. 5. School of Health and Social Studies, Dalarna University, Falun, Sweden. 6. Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden. 7. Deptartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 8. Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. 9. Public Healthcare Services committee, Stockholm County Council, Stockholm, Sweden. 10. Center for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. 11. Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: Chronic kidney disease (CKD) is common, but the frequency of albuminuria testing and referral to nephrology care has been difficult to measure. We here characterize CKD prevalence and recognition in a complete healthcare utilization cohort of the Stockholm region, in Sweden. METHODS: We included all adult individuals (n = 1 128 058) with at least one outpatient measurement of IDMS-calibrated serum creatinine during 2006-11. Estimated glomerular filtration rate (eGFR) was calculated via the CKD-EPI equation and CKD was solely defined as eGFR <60 mL/min/1.73 m2. We also assessed the performance of diagnostic testing (albuminuria), nephrology consultations, and utilization of ICD-10 diagnoses. RESULTS: A total of 68 894 individuals had CKD, with a crude CKD prevalence of 6.11% [95% confidence interval (CI): 6.07-6.16%] and a prevalence standardized to the European population of 5.38% (5.33-5.42%). CKD was more prevalent among the elderly (28% prevalence >75 years old), women (6.85 versus 5.24% in men), and individuals with diabetes (17%), hypertension (17%) or cardiovascular disease (31%). The frequency of albuminuria monitoring was low, with 38% of diabetics and 27% of CKD individuals undergoing albuminuria testing over 2 years. Twenty-three per cent of the 16 383 individuals satisfying selected KDIGO criteria for nephrology referral visited a nephrologist. Twelve per cent of CKD patients carried an ICD-10 diagnostic code of CKD. CONCLUSIONS: An estimated 6% of the adult Stockholm population accessing healthcare has CKD, but the frequency of albuminuria testing, nephrology consultations and registration of CKD diagnoses was suboptimal despite universal care. Improving provider awareness and treatment of CKD could have a significant public health impact.
BACKGROUND:Chronic kidney disease (CKD) is common, but the frequency of albuminuria testing and referral to nephrology care has been difficult to measure. We here characterize CKD prevalence and recognition in a complete healthcare utilization cohort of the Stockholm region, in Sweden. METHODS: We included all adult individuals (n = 1 128 058) with at least one outpatient measurement of IDMS-calibrated serum creatinine during 2006-11. Estimated glomerular filtration rate (eGFR) was calculated via the CKD-EPI equation and CKD was solely defined as eGFR <60 mL/min/1.73 m2. We also assessed the performance of diagnostic testing (albuminuria), nephrology consultations, and utilization of ICD-10 diagnoses. RESULTS: A total of 68 894 individuals had CKD, with a crude CKD prevalence of 6.11% [95% confidence interval (CI): 6.07-6.16%] and a prevalence standardized to the European population of 5.38% (5.33-5.42%). CKD was more prevalent among the elderly (28% prevalence >75 years old), women (6.85 versus 5.24% in men), and individuals with diabetes (17%), hypertension (17%) or cardiovascular disease (31%). The frequency of albuminuria monitoring was low, with 38% of diabetics and 27% of CKD individuals undergoing albuminuria testing over 2 years. Twenty-three per cent of the 16 383 individuals satisfying selected KDIGO criteria for nephrology referral visited a nephrologist. Twelve per cent of CKD patients carried an ICD-10 diagnostic code of CKD. CONCLUSIONS: An estimated 6% of the adult Stockholm population accessing healthcare has CKD, but the frequency of albuminuria testing, nephrology consultations and registration of CKD diagnoses was suboptimal despite universal care. Improving provider awareness and treatment of CKD could have a significant public health impact.
Authors: L A Phillips; B M Phillips; S Meran; J Russell; S Zouwail; S G Riley; A O Phillips Journal: Eur J Intern Med Date: 2013-08-28 Impact factor: 4.487
Authors: Navdeep Tangri; Morgan E Grams; Andrew S Levey; Josef Coresh; Lawrence J Appel; Brad C Astor; Gabriel Chodick; Allan J Collins; Ognjenka Djurdjev; C Raina Elley; Marie Evans; Amit X Garg; Stein I Hallan; Lesley A Inker; Sadayoshi Ito; Sun Ha Jee; Csaba P Kovesdy; Florian Kronenberg; Hiddo J Lambers Heerspink; Angharad Marks; Girish N Nadkarni; Sankar D Navaneethan; Robert G Nelson; Stephanie Titze; Mark J Sarnak; Benedicte Stengel; Mark Woodward; Kunitoshi Iseki Journal: JAMA Date: 2016-01-12 Impact factor: 56.272
Authors: Chaoyang Li; Xiao-Jun Wen; Meda E Pavkov; Guixiang Zhao; Lina S Balluz; Earl S Ford; Desmond Williams; Carol A Gotway Journal: Am J Nephrol Date: 2014-04-12 Impact factor: 3.754
Authors: Björn Runesson; Alessandro Gasparini; Abdul Rashid Qureshi; Olof Norin; Marie Evans; Peter Barany; Björn Wettermark; Carl Gustaf Elinder; Juan Jesús Carrero Journal: Clin Kidney J Date: 2015-11-14
Authors: Ana C Ricardo; Wei Yang; Daohang Sha; Lawrence J Appel; Jing Chen; Marie Krousel-Wood; Anjella Manoharan; Susan Steigerwalt; Jackson Wright; Mahboob Rahman; Sylvia E Rosas; Milda Saunders; Kumar Sharma; Martha L Daviglus; James P Lash Journal: J Am Soc Nephrol Date: 2018-12-03 Impact factor: 10.121
Authors: Per Wändell; Axel C Carlsson; Xinjun Li; Danijela Gasevic; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist Journal: Am J Nephrol Date: 2019-02-01 Impact factor: 3.754
Authors: Juan Jesus Carrero; Marco Trevisan; Manish M Sood; Peter Bárány; Hong Xu; Marie Evans; Leif Friberg; Karolina Szummer Journal: Clin J Am Soc Nephrol Date: 2018-07-20 Impact factor: 8.237
Authors: D Miyaoka; Y Imanishi; M Ohara; N Hayashi; Y Nagata; S Yamada; K Mori; M Emoto; M Inaba Journal: Osteoporos Int Date: 2018-09-05 Impact factor: 4.507
Authors: Chi D Chu; Charles E McCulloch; Tanushree Banerjee; Meda E Pavkov; Nilka R Burrows; Brenda W Gillespie; Rajiv Saran; Michael G Shlipak; Neil R Powe; Delphine S Tuot Journal: Am J Kidney Dis Date: 2020-04-15 Impact factor: 8.860